Exogenous CXCL4 infusion inhibits macrophage phagocytosis by limiting CD36 signalling to enhance post-myocardial infarction cardiac dilation and mortality-Reference-Cited by-同舟云学术

Exogenous CXCL4 infusion inhibits macrophage phagocytosis by limiting CD36 signalling to enhance post-myocardial infarction cardiac dilation and mortality

Published:2018-08-29 Issue:2 Volume:115 Page:395-408
ISSN:0008-6363
Container-title:Cardiovascular Research
language:en
Short-container-title:

Author:

Lindsey Merry L¹²,Jung Mira¹,Yabluchanskiy Andriy³,Cannon Presley L¹,Iyer Rugmani Padmanabhan¹,Flynn Elizabeth R¹,DeLeon-Pennell Kristine Y¹²,Valerio Fritz M¹,Harrison Courtney L¹,Ripplinger Crystal M⁴,Hall Michael E¹⁵,Ma Yonggang¹

Affiliation:

1. Department of Physiology and Biophysics, Mississippi Center for Heart Research, University of Mississippi Medical Center, 2500 North State St., Jackson, MS, USA

2. Research Service, G.V. (Sonny) Montgomery Veterans Affairs Medical Center, Jackson, MS, USA

3. Department of Geriatric Medicine, Translational Geroscience Laboratory, Reynolds Oklahoma Center on Aging, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA

4. Department of Pharmacology, School of Medicine, University of California, Davis, Davis, CA, USA

5. Department of Medicine, Division of Cardiology, University of Mississippi Medical Center, Jackson, MS, USA

Funder

National Institutes of Health

Biomedical Laboratory Research

Development Service of the Veterans Affairs Office of Research and Development

American Heart Association

Veterans Administration

Publisher

Oxford University Press (OUP)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine,Physiology